Table 1 Correlations between ERRβsf/ERRβ and clinicopathological characteristics in ESCC patients
Characteristic | All patients, N = 54 | ERRβsf/ERRβ | P value | |
|---|---|---|---|---|
Low, N = 18 | High, N = 36 | |||
Age, year (IQR) | 67.5 (62.0–72.3) | 68.5 (62.0–72.0) | 66.5 (62.0–73.0) | 0.912a |
Gender, n (%) | 0.053b | |||
Male | 39 (72.2) | 16 (88.9) | 23 (63.9) | |
Female | 15 (27.8) | 2 (11.1) | 13 (36.1) | |
BMI (IQR) | 21.94 (19.94–24.28) | 22.05 (20.51–24.28) | 21.50 (19.85–24.56) | 0.754a |
Tumor length, n (%) | 0.188b | |||
≤ 3 cm | 24 (44.5) | 5 (27.8) | 19 (52.8) | |
3 cm–5 cm | 20 (37.0) | 8 (44.4) | 12 (33.3) | |
≥ 5 cm | 10 (18.5) | 5 (27.8) | 5 (13.9) | |
Location, n (%) | 1.000b | |||
Upper | 3 (5.6) | 1 (5.6) | 2 (5.6) | |
Middle | 39 (72.2) | 13 (72.2) | 26 (72.2) | |
Lower | 12 (22.2) | 4 (22.2) | 8 (22.2) | |
G stage, n (%) | 0.606b | |||
G1 | 17 (31.5) | 4 (22.2) | 13 (36.1) | |
G2 | 30 (55.5) | 11 (61.1) | 19 (52.8) | |
G3 | 7 (13.0) | 3 (16.7) | 4 (11.1) | |
T stage, n (%) | 0.554b | |||
T1–2 | 18 (33.3) | 8 (38.1) | 10 (30.3) | |
T3 | 36 (66.7) | 13 (61.9) | 23 (69.7) | |
N stage, n (%) | 0.846b | |||
N0 | 18 (33.3) | 10 (32.3) | 8 (34.8) | |
N1–3 | 36 (66.7) | 21 (67.7) | 15 (65.2) | |
pTNM stage, n (%) | 0.695b | |||
I–II | 18 (33.3) | 10 (31.2) | 8 (36.4) | |
III–IV | 36 (66.7) | 22 (68.8) | 14 (63.6) | |